Home › Employers › BioCheck, Inc.
BioCheck, Inc.: H-1B salaries and sponsorship
BioCheck, Inc. filed 3 labor condition applications for H-1B and related visas in fiscal years 2023–2026; certified: 3. Median offered salary: $145,000.
Does BioCheck, Inc. sponsor H-1B visas?
BioCheck, Inc. filed 3 labor condition applications in fiscal years 2023–2026, the latest submitted on May 28, 2026. An LCA is the first step of an H-1B petition, so the employer has sponsored or prepared to sponsor H-1B workers; it does not guarantee sponsorship for any particular job. Check the employer's own job listings.
Salaries by job title
| Job title | LCAs | Median salary |
|---|---|---|
| Director of Engineering | 1 | $165,000 |
| Associate Director of Immunoassay Development | 1 | $145,000 |
| Scientist II-Diagnostic Development | 1 | $120,000 |
Applications by fiscal year
| Fiscal year | LCAs | Median salary |
|---|---|---|
| FY2023 | 1 | $165,000 |
| FY2024 | 1 | $145,000 |
| FY2026 | 1 | $120,000 |
Prevailing wage levels
The Department of Labor sets four prevailing wage levels for each occupation and area, from Level I (entry) to Level IV (fully competent). The employer picks the level that matches the job's requirements.
Where the jobs are
Occupations
Latest applications
| Job title | Base salary | Location | Submitted | Start date | Status |
|---|---|---|---|---|---|
| Scientist II-Diagnostic Development | $120,000 Level I | Pleasant Hill, CA | May 28, 2026 | Oct 1, 2026 | Certified |
| Associate Director of Immunoassay Development | $145,000 Level III | South San Francisco, CA | May 20, 2024 | May 28, 2024 | Certified |
| Director of Engineering | $165,000 Level IV | South San Francisco, CA | Jan 20, 2023 | May 4, 2023 | Certified |
Salaries are the lower end of the wage offered on each application, converted to a yearly amount; statistics use certified full-time applications only. An LCA is not a visa approval and one LCA can cover several positions. Source: U.S. Department of Labor, OFLC LCA Disclosure Data, fiscal years 2023–2026 (latest decision Jun 30, 2026).